BCR and myeloproliferative neoplasm: At a physiopathological level, BCR::ABL1-negative MPN (including PV, ET and PMF) are mainly characterized by a medullar hyperplasia with repercussions on one or more blood cells lines and by a trend to extramedullary hematopoiesis [20].